GlassScriptPhysician profile
Joni S Canby
NPI 1144222068
$1,774.82
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $765 · 2020: $824 · 2021: $186.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $318.68 | 2019-2021 | |
| Abbvie INC. | $317.77 | 2019-2021 | |
| Radius Health, INC. | $163.84 | 2019-2021 | |
| Exeltis, USA INC. | $126.74 | 2019-2021 | |
| Amgen INC. | $98.56 | 2019-2020 | |
| Allergan, INC. | $90.79 | 2019-2020 | |
| Daiichi Sankyo INC. | $66.34 | 2020 | |
| Mylan Pharmaceuticals INC. | $61.16 | 2019-2020 | |
| Lupin INC. | $58.50 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.48 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $42.75 | 2019 | |
| Minerva Surgical, INC | $39.48 | 2021 | |
| Avion Pharmaceuticals | $39.08 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $37.18 | 2020 | |
| Ethicon US, LLC | $37.12 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $36.76 | 2019 | |
| Davol INC. | $31.04 | 2019 | |
| Evofem Biosciences, INC. | $31.02 | 2020-2021 | |
| Roche Diagnostics Corporation | $27.06 | 2019 | |
| Sanofi Pasteur INC. | $26.84 | 2019 | |
| Agile Therapeutics, INC. | $19.80 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2020 | |
| Novo Nordisk INC | $12.20 | 2019 | |
| Covidien LP | $11.11 | 2019 | |
| Astellas Pharma US INC | $11.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joni Canby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.